205 related articles for article (PubMed ID: 33442399)
21. PGAM5 expression and macrophage signatures in non-small cell lung cancer associated with chronic obstructive pulmonary disease (COPD).
Ng Kee Kwong F; Nicholson AG; Pavlidis S; Adcock IM; Chung KF
BMC Cancer; 2018 Dec; 18(1):1238. PubMed ID: 30526542
[TBL] [Abstract][Full Text] [Related]
22. Microarray analysis of the expression profile of immune-related gene in rapid recurrence early-stage lung adenocarcinoma.
Liu J; Yang X; Zhang L; Yang B; Rao W; Li M; Dai N; Yang Y; Qian C; Zhang L; Xiao H; Wang D
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2299-2310. PubMed ID: 32556504
[TBL] [Abstract][Full Text] [Related]
23. Identification of common signatures in idiopathic pulmonary fibrosis and lung cancer using gene expression modeling.
Leng D; Yi J; Xiang M; Zhao H; Zhang Y
BMC Cancer; 2020 Oct; 20(1):986. PubMed ID: 33046043
[TBL] [Abstract][Full Text] [Related]
24. Bioinformatics Analysis of Microarray Datasets to Identify Prognostic Factors in Lung Adenocarcinoma.
Jin X; Xu L; Guan Y; Zhang Z; Li H
DNA Cell Biol; 2020 Jun; 39(6):965-974. PubMed ID: 32330391
[TBL] [Abstract][Full Text] [Related]
25. A Six-Gene Signature Predicts Survival of Adenocarcinoma Type of Non-Small-Cell Lung Cancer Patients: A Comprehensive Study Based on Integrated Analysis and Weighted Gene Coexpression Network.
Xie H; Xie C
Biomed Res Int; 2019; 2019():4250613. PubMed ID: 31886214
[No Abstract] [Full Text] [Related]
26. CD19 and POU2AF1 are Potential Immune-Related Biomarkers Involved in the Emphysema of COPD: On Multiple Microarray Analysis.
Zhang DW; Ye JJ; Sun Y; Ji S; Kang JY; Wei YY; Fei GH
J Inflamm Res; 2022; 15():2491-2507. PubMed ID: 35479834
[TBL] [Abstract][Full Text] [Related]
27. Identification of Potential Key Genes in the Pathogenesis of Chronic Obstructive Pulmonary Disease Through Bioinformatics Analysis.
Guan Q; Tian Y; Zhang Z; Zhang L; Zhao P; Li J
Front Genet; 2021; 12():754569. PubMed ID: 34804123
[TBL] [Abstract][Full Text] [Related]
28. Identification of novel biomarkers and candidate small molecule drugs in non-small-cell lung cancer by integrated microarray analysis.
Wu Q; Zhang B; Sun Y; Xu R; Hu X; Ren S; Ma Q; Chen C; Shu J; Qi F; He T; Wang W; Wang Z
Onco Targets Ther; 2019; 12():3545-3563. PubMed ID: 31190860
[No Abstract] [Full Text] [Related]
29. Identification of key genes for predicting colorectal cancer prognosis by integrated bioinformatics analysis.
Dai GP; Wang LP; Wen YQ; Ren XQ; Zuo SG
Oncol Lett; 2020 Jan; 19(1):388-398. PubMed ID: 31897151
[TBL] [Abstract][Full Text] [Related]
30. Immune Characteristics Analysis and Transcriptional Regulation Prediction Based on Gene Signatures of Chronic Obstructive Pulmonary Disease.
Yu H; Guo W; Liu Y; Wang Y
Int J Chron Obstruct Pulmon Dis; 2021; 16():3027-3039. PubMed ID: 34764646
[TBL] [Abstract][Full Text] [Related]
31. Identification of Potential Crucial Genes and Key Pathways in Breast Cancer Using Bioinformatic Analysis.
Deng JL; Xu YH; Wang G
Front Genet; 2019; 10():695. PubMed ID: 31428132
[No Abstract] [Full Text] [Related]
32. Investigation of differentially-expressed microRNAs and genes in cervical cancer using an integrated bioinformatics analysis.
Xu Z; Zhou Y; Shi F; Cao Y; Dinh TLA; Wan J; Zhao M
Oncol Lett; 2017 Apr; 13(4):2784-2790. PubMed ID: 28454467
[TBL] [Abstract][Full Text] [Related]
33. Impact of severe-to-very severe chronic obstructive pulmonary disease on the prognosis of patients with non-small cell lung cancer who received chemotherapy.
Dong W; Zhu Y; Du Y; Wang L; Feng X; Ma S
Clin Respir J; 2020 Apr; 14(4):345-352. PubMed ID: 31876095
[TBL] [Abstract][Full Text] [Related]
34. Target gene screening and evaluation of prognostic values in non-small cell lung cancers by bioinformatics analysis.
Piao J; Sun J; Yang Y; Jin T; Chen L; Lin Z
Gene; 2018 Mar; 647():306-311. PubMed ID: 29305979
[TBL] [Abstract][Full Text] [Related]
35. Tripartite motif-containing 15 overexpression in non-small cell lung cancer is associated with poor patient prognoses.
Han X; Huang C; Qu X; Liu S; Yang X; Wang Y; Bie F; Liu Q; Du J
J Cancer; 2019; 10(4):843-852. PubMed ID: 30854090
[No Abstract] [Full Text] [Related]
36. Differential Expression and Bioinformatics Analysis of circRNA in Non-small Cell Lung Cancer.
Sun Q; Li X; Xu M; Zhang L; Zuo H; Xin Y; Zhang L; Gong P
Front Genet; 2020; 11():586814. PubMed ID: 33329727
[TBL] [Abstract][Full Text] [Related]
37. A robust six-gene prognostic signature for prediction of both disease-free and overall survival in non-small cell lung cancer.
Zuo S; Wei M; Zhang H; Chen A; Wu J; Wei J; Dong J
J Transl Med; 2019 May; 17(1):152. PubMed ID: 31088477
[TBL] [Abstract][Full Text] [Related]
38. Identification of Key Genes and Prognostic Analysis between Chromophobe Renal Cell Carcinoma and Renal Oncocytoma by Bioinformatic Analysis.
Wu H; Fan L; Liu H; Guan B; Hu B; Liu F; Hocher B; Yin L
Biomed Res Int; 2020; 2020():4030915. PubMed ID: 31998788
[TBL] [Abstract][Full Text] [Related]
39. Prediction of key genes and miRNAs responsible for loss of muscle force in patients during an acute exacerbation of chronic obstructive pulmonary disease.
Duan Y; Zhou M; Xiao J; Wu C; Zhou L; Zhou F; Du C; Song Y
Int J Mol Med; 2016 Nov; 38(5):1450-1462. PubMed ID: 28025995
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive analysis of non-small-cell lung cancer microarray datasets identifies several prognostic biomarkers.
Qin X; Chen R; Xiong R; Tan Z; Gao S; Lin C; Huo T
Future Oncol; 2019 Sep; 15(27):3135-3148. PubMed ID: 31426680
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
